(Reuters) -Pfizer said on Monday it would acquire weight-loss drug developer Metsera for up to $4.9 billion to secure its position in the lucrative obesity treatment market.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion
